🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 78 (from laksa071)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa078.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://www.idsociety.org/ID-topics/infectious-disease/covid-19/\')), getAhrefsUnparsedNoserviceFromURL(\'https://www.idsociety.org/ID-topics/infectious-disease/covid-19/\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/covid-19\/","crawl_time":1776064068,"first_indexed_time":1746079062,"http_code":200,"src_unparsed":"org,idsociety!www,\/ID-topics\/infectious-disease\/covid-19\/ s443","src_root_hash":"11347771854328970478","history_drop_reason":null,"meta_title":"COVID-19","meta_descriptions":["COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. It can be very contagious and can spread quickly."],"attrs_boilerpipe_text":"Coronavirus disease 2019, or COVID-19, is an infectious disease caused by the SARS-CoV-2 virus. It can be very contagious and can spread quickly. Since 2020, more than 1.2 million people have died of COVID-19 in the U.S.\nMore about COVID-19\nPeople with COVID-19 may have a wide range of symptoms ranging from mild symptoms to severe illness. Possible symptoms include fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting, and diarrhea.\nSeveral antiviral medications are available that can reduce risk of hospitalization and death for people with COVID-19 who are more likely to get very sick. To be effective, treatments must be started within five to seven days after symptoms first develop.\nPeople who are more likely to get very sick include adults over 65, people who are not vaccinated or not up to date on their COVID-19 vaccinations, or people with certain medical conditions, such as chronic lung disease, heart disease or a weakened immune system.\nThere are several core prevention strategies that everyone can use to help to protect themselves and others from respiratory viruses, including COVID-19. These include good hygiene (covering your coughs and sneezes, washing or sanitizing your hands often, and cleaning frequently touched surfaces), taking steps for cleaner air and staying home when sick.\nStaying up to date on COVID-19 vaccines significantly lowers the risk of getting very sick, being hospitalized or dying from COVID-19. The COVID-19 vaccine is recommended for everyone ages 6 months and older and is regularly updated to protect against the currently circulating viral strains. It is especially important to get an updated COVID-19 vaccine if you are aged 65 and older, or if you are at high risk for severe COVID-19. COVID-19 vaccination has also been shown to lower your risk of developing long COVID.\nAdditional strategies like wearing a mask and putting distance between yourself and others can help lower the risk of spreading COVID-19 and other respiratory viruses. Testing for COVID-19 can help you decide what to do next, like getting treatment to reduce your risk of severe illness and taking steps to lower your chances of spreading COVID-19 to others.","attrs_markdown":"Advertisement\n\n[Skip to nav](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/covid-19\/#idsa-main-nav) [Skip to content](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/covid-19\/#idsa-main-content)\n\n- [IDSA](https:\/\/www.idsociety.org\/)\n- [Foundation](https:\/\/www.idsafoundation.org\/)\n- [IDWeek](https:\/\/idweek.org\/)\n- [HIVMA](https:\/\/www.hivma.org\/)\n\n- [About](https:\/\/www.idsociety.org\/about-us\/)\n- [Guidelines](https:\/\/www.idsociety.org\/practice-guideline\/all-practice-guidelines\/)\n- [Journals](https:\/\/www.idsociety.org\/journals\/journals--publications\/)\n- [Events](https:\/\/www.idsociety.org\/event-listing\/)\n- [Blog](https:\/\/www.idsociety.org\/science-speaks-blog\/)\n- [News](https:\/\/www.idsociety.org\/news--publications-new\/)\n- [Login](https:\/\/www.idsociety.org\/login\/?returnUrl=%2FID-topics%2Finfectious-disease%2Fcovid-19%2F)\n\n[![](https:\/\/www.idsociety.org\/contentassets\/6d9bd5c5d90b4071b89b11f5ab2f294b\/idsa-logo-green.png)](https:\/\/www.idsociety.org\/)\n\n[![](https:\/\/www.idsociety.org\/contentassets\/6d9bd5c5d90b4071b89b11f5ab2f294b\/idsa-logo-green.png)](https:\/\/www.idsociety.org\/)\n\n- Clinical Resources\n  Clinical Resources\n  - Guidelines\n    Guidelines\n    - [A-Z Guideline Listing](https:\/\/www.idsociety.org\/practice-guideline\/all-practice-guidelines\/)\n    - [Search All Guidelines](https:\/\/www.idsociety.org\/practice-guideline\/practice-guidelines\/)\n    - [Training & Resources](https:\/\/www.idsociety.org\/clinical-practice-guidelines-development-training-and-resources\/)\n  - Featured Guidelines\n    Featured Guidelines\n    - [AMR Guidance](https:\/\/www.idsociety.org\/practice-guideline\/amr-guidance\/)\n    - [Community-Acquired Pneumonia in Adults](https:\/\/www.idsociety.org\/practice-guideline\/community-acquired-pneumonia-cap-in-adults\/)\n    - [Complicated Urinary Tract Infections](https:\/\/www.idsociety.org\/practice-guideline\/complicated-urinary-tract-infections\/)\n    - [Skin and Soft Tissue Infections](https:\/\/www.idsociety.org\/practice-guideline\/skin-and-soft-tissue-infections\/)\n  - Practice Tools\n    Practice Tools\n    - [Antimicrobial Stewardship](https:\/\/www.idsociety.org\/practice-resources\/practice-tools\/antimicrobial-stewardship\/)\n    - [Coding and Payment](https:\/\/www.idsociety.org\/practice-resources\/practice-tools\/coding-and-payment\/)\n    - [ID Physician Compensation](https:\/\/www.idsociety.org\/practice-resources\/professional-development\/id-physician-compensation-initiative\/)\n    - [Quality Measurement and Improvement](https:\/\/www.idsociety.org\/practice-resources\/practice-tools\/quality-measurement-and-improvement\/)\n  \n  ![](https:\/\/www.idsociety.org\/globalassets\/new-branding-photos\/intern.png?width=420&height=240&format=webp&rxy=0.5%2C0.5&rmode=crop)\n  \n  Guidelines\n  \n  [View all Practice Guidelines](https:\/\/www.idsociety.org\/practice-guideline\/practice-guidelines\/)\n- [Health Topics]()\n  [Health Topics]()\n  - Infectious Diseases\n    Infectious Diseases\n    - [Avian Influenza A(H5N1)](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/avian-influenza-h5n1\/)\n    - [COVID-19](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/covid-19\/)\n    - [Ebola](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/ebola\/)\n    - [Influenza](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/influenza\/)\n    - [Lyme Disease](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/lyme-disease\/)\n    - [Measles](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/measles\/)\n    - [Mpox](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/mpox\/)\n    - [Viral Hepatitis](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/Viral-hepatitis\/)\n  - Special Topics\n    Special Topics\n    - [Antimicrobial Resistance](https:\/\/www.idsociety.org\/ID-topics\/special-topics\/antimicrobial-resistance\/)\n    - [Climate Change](https:\/\/www.idsociety.org\/ID-topics\/special-topics\/climate-change\/)\n    - [Emerging Infections](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/emerging-infections-and-infectious-threats\/)\n    - [Hurricanes and Flooding](https:\/\/www.idsociety.org\/ID-topics\/special-topics\/hurricane-resources\/)\n    - [Immunization & Vaccination](https:\/\/www.idsociety.org\/ID-topics\/special-topics\/immunization\/)\n  \n  ![](https:\/\/www.idsociety.org\/globalassets\/new-branding-photos\/intern.png?width=420&height=240&format=webp&rxy=0.5%2C0.5&rmode=crop)\n  \n  Guidelines\n  \n  [Looking for Practice Guidelines?](https:\/\/www.idsociety.org\/practice-guideline\/all-practice-guidelines\/)\n- Education\n  Education\n  - Professional Development\n    Professional Development\n    - [IDSA Academy](https:\/\/academy.idsociety.org\/)\n    - [iDMentorship365](https:\/\/www.idsociety.org\/practice-resources\/professional-development\/idmentorship365-program\/)\n    - [ID STEP Program](https:\/\/www.idsociety.org\/practice-resources\/grants-and-funding\/id-spark-train-educate-and-prepare-program\/)\n    - [Leadership Institute](https:\/\/www.idsociety.org\/education--training\/idsa-leadership-institute\/)\n  - Training and Curriculum\n    Training and Curriculum\n    - [Fellows-in-Training Career Resources](https:\/\/www.idsociety.org\/education--training\/training-and-curriculum\/fellows-in-training-resources\/)\n    - [ID Fellowship Match](https:\/\/www.idsociety.org\/education--training\/training-and-curriculum\/id-fellowship-match\/)\n    - [ID Fellowship Training Program Directory](https:\/\/www.idsociety.org\/education--training\/training-and-curriculum\/id-fellowship-training-program-directory\/)\n    - [Jobs in ID](https:\/\/www.idsociety.org\/education--training\/jobs-in-id\/)\n    - [Training Program Director Resources](https:\/\/www.idsociety.org\/education--training\/training-and-curriculum\/fellows-in-training-resources\/training-program-director-resources\/)\n  \n  ![](https:\/\/www.idsociety.org\/globalassets\/new-branding-photos\/the-work_06_shot-of-a-young-man-writing-on-a-whiteboard-while-students-look-on.jpg?width=420&height=240&format=webp&quality=100&rxy=0.44%2C0.42&rmode=crop)\n  \n  training\n  \n  [Browse IDSA Academy Courses](https:\/\/academy.idsociety.org\/)\n- [Policy & Advocacy]()\n  [Policy & Advocacy]()\n  - Advocacy and Action\n    Advocacy and Action\n    - [Advocacy](https:\/\/www.idsociety.org\/policy--advocacy\/advocacy\/)\n    - [Federal Policy Watch](https:\/\/www.idsociety.org\/policy--advocacy\/federal-policy-watch\/)\n    - [Take Action](https:\/\/idsociety.quorum.us\/home_page\/)\n    - [Member Advocacy Program](https:\/\/www.idsociety.org\/policy--advocacy\/member-advocacy-program\/)\n  - IDSA Policy and Priorities\n    IDSA Policy and Priorities\n    - [Access & Reimbursement](https:\/\/www.idsociety.org\/policy--advocacy\/reimbursement-and-compensation\/)\n    - [Antimicrobial Resistance](https:\/\/www.idsociety.org\/ID-topics\/special-topics\/antimicrobial-resistance\/)\n    - [Diagnostics](https:\/\/www.idsociety.org\/policy--advocacy\/diagnostics\/)\n    - [Funding Policy](https:\/\/www.idsociety.org\/policy--advocacy\/funding\/)\n    - [Global Health](https:\/\/www.idsociety.org\/policy--advocacy\/global-health\/)\n  - Professional Practice Advocacy\n    Professional Practice Advocacy\n    - [Bio-Preparedness Workforce Pilot](https:\/\/www.idsociety.org\/policy--advocacy\/bio-preparedness-workforce-pilot-program\/)\n    - [ID Workforce Initiative](https:\/\/www.idsociety.org\/practice-resources\/professional-development\/id-workforce\/)\n    - [National PrEP Program](https:\/\/www.hivma.org\/policy--advocacy\/professional-practice-advocacy\/national-prep-program\/)\n  \n  ![](https:\/\/www.idsociety.org\/globalassets\/global-blocks\/hero-blocks\/hero-3.jpg?width=420&height=240&format=webp&quality=100&rxy=0.5%2C0.5&rmode=crop)\n  \n  Advocacy\n  \n  [Become an IDSA\/HIVMA Advocate\\!](https:\/\/idsociety.quorum.us\/home_page\/)\n- [Membership]()\n  [Membership]()\n  - Membership Services\n    Membership Services\n    - [Fellow of IDSA](https:\/\/www.idsociety.org\/membership-community\/fellow-of-idsa\/)\n    - [Benefits of Membership](https:\/\/www.idsociety.org\/membership-community\/membership\/)\n    - [Join IDSA](https:\/\/profile.idsociety.org\/s\/joinrenewidsa)\n    - [Membership Renewal](https:\/\/profile.idsociety.org\/s\/my-profile\/memberships)\n    - [MyIDSA](https:\/\/my.idsociety.org\/home)\n  - Networking\n    Networking\n    - [Medical Education Community of Practice](https:\/\/www.idsociety.org\/membership-community\/medical-education-community-of-practice\/)\n    - [EIN (Emerging Infections Network)](https:\/\/ein.idsociety.org\/)\n    - [Member Directory](https:\/\/my.idsociety.org\/network\/members)\n    - [Member interest groups](https:\/\/www.idsociety.org\/membership-community\/member-interest-groups\/)\n    - [State & Regional Affiliate Program](https:\/\/www.idsociety.org\/membership-community\/state-and-regional-affiliate-program\/)\n  - Opportunities\n    Opportunities\n    - [Events](https:\/\/www.idsociety.org\/event-listing\/)\n    - [Funding Opportunities](https:\/\/www.idsociety.org\/practice-resources\/grants-and-funding\/funding-alerts\/)\n    - [Society Awards](https:\/\/www.idsociety.org\/about-us\/awards\/society-awards\/)\n    - [Past Award Lecturers](https:\/\/www.idsociety.org\/about-us\/lecturers\/past-award-lecturers\/)\n    - [Volunteer Opportunities](https:\/\/www.idsociety.org\/membership-community\/volunteer-opportunities\/)\n  \n  ![](https:\/\/www.idsociety.org\/globalassets\/idsa\/jobs-in-id\/idsa_jobseeker_mobile-1.png?width=420&height=240&format=webp&rxy=0.5%2C0.5&rmode=crop)\n  \n  Career\n  \n  [Find your next role in ID\\!](https:\/\/www.idsociety.org\/education--training\/jobs-in-id\/)\n\n- [About](https:\/\/www.idsociety.org\/about-us\/)\n- [Guidelines](https:\/\/www.idsociety.org\/practice-guideline\/all-practice-guidelines\/)\n- [Journals](https:\/\/www.idsociety.org\/journals\/journals--publications\/)\n- [Events](https:\/\/www.idsociety.org\/event-listing\/)\n- [Blog](https:\/\/www.idsociety.org\/science-speaks-blog\/)\n- [News](https:\/\/www.idsociety.org\/news--publications-new\/)\n- [Login](https:\/\/www.idsociety.org\/login\/?returnUrl=%2FID-topics%2Finfectious-disease%2Fcovid-19%2F)\n\n# COVID-19\n![](https:\/\/www.idsociety.org\/globalassets\/idsa\/health-topics\/covid-19\/49535193646_a57e21dcca_o.jpg?width=416&height=416&format=webp&quality=100&rxy=0.5%2C0.5&rmode=crop)\n\nCoronavirus disease 2019, or COVID-19, is an infectious disease caused by the SARS-CoV-2 virus. It can be very contagious and can spread quickly. Since 2020, more than 1.2 million people have died of COVID-19 in the U.S.\n\n## More about COVID-19\nSymptoms and Treatment\n\nPeople with COVID-19 may have a wide range of symptoms ranging from mild symptoms to severe illness. Possible symptoms include fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting, and diarrhea.\n\nSeveral antiviral medications are available that can reduce risk of hospitalization and death for people with COVID-19 who are more likely to get very sick. To be effective, treatments must be started within five to seven days after symptoms first develop.\n\nPeople who are more likely to get very sick include adults over 65, people who are not vaccinated or not up to date on their COVID-19 vaccinations, or people with certain medical conditions, such as chronic lung disease, heart disease or a weakened immune system.\n\nPrevention\n\nThere are several core prevention strategies that everyone can use to help to protect themselves and others from respiratory viruses, including COVID-19. These include good hygiene (covering your coughs and sneezes, washing or sanitizing your hands often, and cleaning frequently touched surfaces), taking steps for cleaner air and staying home when sick.\n\nStaying up to date on COVID-19 vaccines significantly lowers the risk of getting very sick, being hospitalized or dying from COVID-19. The COVID-19 vaccine is recommended for everyone ages 6 months and older and is regularly updated to protect against the currently circulating viral strains. It is especially important to get an updated COVID-19 vaccine if you are aged 65 and older, or if you are at high risk for severe COVID-19. COVID-19 vaccination has also been shown to lower your risk of developing long COVID.\n\nAdditional strategies like wearing a mask and putting distance between yourself and others can help lower the risk of spreading COVID-19 and other respiratory viruses. Testing for COVID-19 can help you decide what to do next, like getting treatment to reduce your risk of severe illness and taking steps to lower your chances of spreading COVID-19 to others.\n\n## The latest\nBravoSquared Search\n\n[Blog Post Fungi \/ Fungal Infections Hepatitis JID for Clinicians: Chronic pulmonary aspergillosis, the relationship between HBsAG-ICs and hepatitis flares and more Learn about how autoantibody screening could help identify high-risk patients early for COVID-19 treatment, embedding a TNIC approach in vaccine trial designs and other research ready to inform clinical practice.**Last Updated** March 19, 2026 **Authors** Ande Rosado](https:\/\/www.idsociety.org\/science-speaks-blog\/2026\/jid-for-clinicians-chronic-pulmonary-aspergillosis-the-relationship-between-hbsag-ics-and-hepatitis-flares-and-more\/)\n\n[Blog Post COVID-19 Science Speaks Blog Long COVID in India: Clinical patterns, challenges and implications for infectious diseases specialists India’s COVID-19 burden has transitioned from acute pandemic management to long-term sequelae care.**Last Updated** March 16, 2026 **Authors** Kaushik Bharati, PhD, FRSPH](https:\/\/www.idsociety.org\/science-speaks-blog\/2026\/long-covid-in-india-clinical-patterns-challenges-and-implications-for-infectious-diseases-specialists\/)\n\n[Blog Post HIV \/ AIDS COVID-19 JID for Clinicians: On-demand dosing for HIV prevention in women, corticosteroid therapies for cryptococcal meningitis and more Learn more about how vaccination decreased the risk of severe COVID-19 in patients with a history of hematologic malignancy, threats to the diagnostic accuracies of MRSA detection and other research ready to inform clinical practice.**Last Updated** February 24, 2026 **Authors** Ande Rosado](https:\/\/www.idsociety.org\/science-speaks-blog\/2026\/jid-for-clinicians-on-demand-dosing-for-hiv-prevention-in-women-corticosteroid-therapies-for-cryptococcal-meningitis-and-more\/)\n\n[Blog Post COVID-19 Vaccines \/ Immunization Lessons from COVID-19: Vaccine updating and implications for regional health sovereignty The COVID-19 pandemic offers lessons for developing and sustaining vaccine and health sovereignty in Latin America.**Last Updated** February 20, 2026 **Authors** Gabriela Zambrano-Sanchez, MD, Luis Del Carpio-Orantes, MD](https:\/\/www.idsociety.org\/science-speaks-blog\/2026\/lessons-from-covid-19-vaccine-updating-and-implications-for-regional-health-sovereignty\/)\n\nMore\n\n### For the public\n[AAP Parenting Website: When Should Kids Get the COVID Vaccine?](https:\/\/www.healthychildren.org\/English\/health-issues\/conditions\/COVID-19\/Pages\/when-can-kids-get-the-COVID-vaccine-or-booster.aspx)\n\n[AAFP: Fall 2025-2026 Immunization Recommendations](https:\/\/www.aafp.org\/family-physician\/patient-care\/prevention-wellness\/immunizations-vaccines.html)\n\n[ACOG: Maternal Immunization Guidance for COVID-19, Influenza and RSV](https:\/\/www.acog.org\/news\/news-releases\/2025\/08\/acog-releases-updated-maternal-immunization-guidance-covid-influenza-rsv)\n\n[IDSA: IDSA releases COVID-19 vaccine guidelines for people who are immunocompromised](https:\/\/www.idsociety.org\/news--publications-new\/articles\/2025\/idsa-releases-covid-19-vaccine-guidelines-for-people-who-are-immunocompromised\/)\n\n[CDC: COVID-19](https:\/\/www.cdc.gov\/covid\/)\n\n[CDC: Symptoms of COVID-19](https:\/\/www.cdc.gov\/covid\/signs-symptoms\/index.html)\n\n[CDC: Types of COVID-19 Treatment](https:\/\/www.cdc.gov\/covid\/treatment\/index.html)\n\n[CDC: Long COVID Basics](https:\/\/www.cdc.gov\/long-covid\/about\/index.html)\n\n[IDSA: ID Experts: America’s Link Back to Everyday Life](https:\/\/www.idsociety.org\/globalassets\/value-of-id\/our-response-to-covid-19\/final-covid-action-brief-9.26.22.pdf)\n\n### For clinicians\n[AAP: Recommended Child and Adolescent Immunization Schedule](https:\/\/downloads.aap.org\/AAP\/PDF\/AAP-Immunization-Schedule.pdf)\n\n[AAFP: Fall 2025-2026 Immunization Recommendations](https:\/\/www.aafp.org\/family-physician\/patient-care\/prevention-wellness\/immunizations-vaccines.html)\n\n[ACOG: Maternal Immunization Guidance for COVID-19, Influenza and RSV](https:\/\/www.acog.org\/news\/news-releases\/2025\/08\/acog-releases-updated-maternal-immunization-guidance-covid-influenza-rsv)\n\n[CDC: COVID Data Tracker](https:\/\/covid.cdc.gov\/covid-data-tracker\/#datatracker-home)\n\n[IDSA Guideline: Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza and RSV Infections in Immunocompromised Patients](https:\/\/www.idsociety.org\/Seasonal-RTI-Vaccinations-in-Immunocompromised-Patients\/)\n\n[IDSA Guideline: Treatment and Management of Patients With COVID-19](https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management\/)\n\n[IDSA Guideline: Infection Prevention for Health Care Personnel](https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-infection-prevention\/)\n\n[IDSA Guideline: Molecular Diagnostic Testing](https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-diagnostics\/)\n\n[IDSA Guideline: Serologic Testing](https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-serology\/)\n\n[IDSA Guideline: Antigen Testing](https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-antigen-testing\/)\n\n![Close Table Of Contents](https:\/\/www.idsociety.org\/images\/close_toc.svg)\n\n### Table of Contents\n- [More about COVID-19](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/covid-19\/#toc-heading-bclk-58048)\n- [The latest](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/covid-19\/#toc-heading-bclk-54549)\n- [For the public](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/covid-19\/#toc-heading-bclk-54326)\n- [For clinicians](https:\/\/www.idsociety.org\/ID-topics\/infectious-disease\/covid-19\/#toc-heading-bclk-54327)\n\n![Open Table Of Contents](https:\/\/www.idsociety.org\/images\/open_toc.svg)\n\n![](https:\/\/www.idsociety.org\/contentassets\/6d9bd5c5d90b4071b89b11f5ab2f294b\/logo.png)\n\nPhone: (703) 299-0200\n\n- About IDSA\n  - [About](https:\/\/www.idsociety.org\/about-us\/)\n  - [Board of Directors](https:\/\/www.idsociety.org\/about-us\/board-of-directors\/)\n  - [Contact Us](https:\/\/www.idsociety.org\/global\/contact-us\/)\n  - [Jobs in ID](https:\/\/www.idsociety.org\/education--training\/jobs-in-id\/)\n  - [Inclusion, Diversity, Access and Equity](https:\/\/www.idsociety.org\/about-us\/inclusion-diversity-access--equity\/)\n  - [Industry Relations](https:\/\/www.idsociety.org\/about-us\/industry-relations\/)\n\n- News & Insights\n  - [Value of ID](https:\/\/www.idsociety.org\/value-of-id\/)\n  - [Science Speaks Blog](https:\/\/www.idsociety.org\/science-speaks-blog\/)\n  - [News](https:\/\/www.idsociety.org\/news--publications-new\/)\n  - [Multimedia](https:\/\/www.idsociety.org\/multimedia\/)\n  - [Journals](https:\/\/www.idsociety.org\/journals\/journals--publications\/)\n  - [Events](https:\/\/www.idsociety.org\/event-listing\/)\n\n- Membership & Community\n  - [Volunteer Opportunities](https:\/\/www.idsociety.org\/membership-community\/volunteer-opportunities\/)\n  - [State & Regional Affiliate Program](https:\/\/www.idsociety.org\/membership-community\/state-and-regional-affiliate-program\/)\n  - [Society Awards](https:\/\/www.idsociety.org\/about-us\/awards\/society-awards\/)\n  - [Member Advocacy Program](https:\/\/www.idsociety.org\/policy--advocacy\/member-advocacy-program\/)\n  - [MyIDSA](https:\/\/my.idsociety.org\/home)\n  - [Member Communities](https:\/\/my.idsociety.org\/communities\/allcommunities)\n  - [Join IDSA](https:\/\/www.idsociety.org\/membership-community\/membership\/)\n\n- [*Linkedin*](https:\/\/www.linkedin.com\/company\/idsociety\/)\n- [*Facebook*](https:\/\/www.facebook.com\/IDSociety)\n- [*Instagram*](https:\/\/www.instagram.com\/idsainfo\/)\n- [*Twitter*](https:\/\/twitter.com\/idsainfo)\n- [*Threads*](https:\/\/www.threads.net\/@idsainfo)\n- [*BlueSky*](https:\/\/bsky.app\/profile\/idsainfo.bsky.social)\n\n©2026 Infectious Diseases Society of America\n\n- [Terms of Use](https:\/\/www.idsociety.org\/link\/b2335d30fd854d2fa562016520dfc7cc.aspx)\n- [Privacy Policy](https:\/\/www.idsociety.org\/link\/15ddf31ec52b49eb9b38a308f8ddaed4.aspx)\n\n[![](https:\/\/www.idsociety.org\/globalassets\/footer\/idweek_green_logo.png)](http:\/\/idweek.org\/)\n\n[![](https:\/\/www.idsociety.org\/globalassets\/new-branding-logos\/idsa_fnd_gn.png)](https:\/\/www.idsafoundation.org\/)\n\n[![](https:\/\/www.idsociety.org\/contentassets\/5c603dae86df4e09b9b0101963c08a7d\/hivma_2025_gn.png)](http:\/\/hivma.org\/)\n\n[![](https:\/\/www.idsociety.org\/globalassets\/footer\/ein_green_logo.png)](https:\/\/ein.idsociety.org\/)","attrs_readable_markdown":"Coronavirus disease 2019, or COVID-19, is an infectious disease caused by the SARS-CoV-2 virus. It can be very contagious and can spread quickly. Since 2020, more than 1.2 million people have died of COVID-19 in the U.S.\n\nMore about COVID-19\n\nPeople with COVID-19 may have a wide range of symptoms ranging from mild symptoms to severe illness. Possible symptoms include fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting, and diarrhea.\n\nSeveral antiviral medications are available that can reduce risk of hospitalization and death for people with COVID-19 who are more likely to get very sick. To be effective, treatments must be started within five to seven days after symptoms first develop.\n\nPeople who are more likely to get very sick include adults over 65, people who are not vaccinated or not up to date on their COVID-19 vaccinations, or people with certain medical conditions, such as chronic lung disease, heart disease or a weakened immune system.\n\nThere are several core prevention strategies that everyone can use to help to protect themselves and others from respiratory viruses, including COVID-19. These include good hygiene (covering your coughs and sneezes, washing or sanitizing your hands often, and cleaning frequently touched surfaces), taking steps for cleaner air and staying home when sick.\n\nStaying up to date on COVID-19 vaccines significantly lowers the risk of getting very sick, being hospitalized or dying from COVID-19. The COVID-19 vaccine is recommended for everyone ages 6 months and older and is regularly updated to protect against the currently circulating viral strains. It is especially important to get an updated COVID-19 vaccine if you are aged 65 and older, or if you are at high risk for severe COVID-19. COVID-19 vaccination has also been shown to lower your risk of developing long COVID.\n\nAdditional strategies like wearing a mask and putting distance between yourself and others can help lower the risk of spreading COVID-19 and other respiratory viruses. Testing for COVID-19 can help you decide what to do next, like getting treatment to reduce your risk of severe illness and taking steps to lower your chances of spreading COVID-19 to others.","meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

5 hours ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	0 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://www.idsociety.org/ID-topics/infectious-disease/covid-19/
Last Crawled	2026-04-13 07:07:48 (5 hours ago)
First Indexed	2025-05-01 05:57:42 (11 months ago)
HTTP Status Code	200
Meta Title	COVID-19
Meta Description	COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. It can be very contagious and can spread quickly.
Meta Canonical	null
Boilerpipe Text	Coronavirus disease 2019, or COVID-19, is an infectious disease caused by the SARS-CoV-2 virus. It can be very contagious and can spread quickly. Since 2020, more than 1.2 million people have died of COVID-19 in the U.S. More about COVID-19 People with COVID-19 may have a wide range of symptoms ranging from mild symptoms to severe illness. Possible symptoms include fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting, and diarrhea. Several antiviral medications are available that can reduce risk of hospitalization and death for people with COVID-19 who are more likely to get very sick. To be effective, treatments must be started within five to seven days after symptoms first develop. People who are more likely to get very sick include adults over 65, people who are not vaccinated or not up to date on their COVID-19 vaccinations, or people with certain medical conditions, such as chronic lung disease, heart disease or a weakened immune system. There are several core prevention strategies that everyone can use to help to protect themselves and others from respiratory viruses, including COVID-19. These include good hygiene (covering your coughs and sneezes, washing or sanitizing your hands often, and cleaning frequently touched surfaces), taking steps for cleaner air and staying home when sick. Staying up to date on COVID-19 vaccines significantly lowers the risk of getting very sick, being hospitalized or dying from COVID-19. The COVID-19 vaccine is recommended for everyone ages 6 months and older and is regularly updated to protect against the currently circulating viral strains. It is especially important to get an updated COVID-19 vaccine if you are aged 65 and older, or if you are at high risk for severe COVID-19. COVID-19 vaccination has also been shown to lower your risk of developing long COVID. Additional strategies like wearing a mask and putting distance between yourself and others can help lower the risk of spreading COVID-19 and other respiratory viruses. Testing for COVID-19 can help you decide what to do next, like getting treatment to reduce your risk of severe illness and taking steps to lower your chances of spreading COVID-19 to others.
Markdown	Advertisement [Skip to nav](https://www.idsociety.org/ID-topics/infectious-disease/covid-19/#idsa-main-nav) [Skip to content](https://www.idsociety.org/ID-topics/infectious-disease/covid-19/#idsa-main-content) - [IDSA](https://www.idsociety.org/) - [Foundation](https://www.idsafoundation.org/) - [IDWeek](https://idweek.org/) - [HIVMA](https://www.hivma.org/) - [About](https://www.idsociety.org/about-us/) - [Guidelines](https://www.idsociety.org/practice-guideline/all-practice-guidelines/) - [Journals](https://www.idsociety.org/journals/journals--publications/) - [Events](https://www.idsociety.org/event-listing/) - [Blog](https://www.idsociety.org/science-speaks-blog/) - [News](https://www.idsociety.org/news--publications-new/) - [Login](https://www.idsociety.org/login/?returnUrl=%2FID-topics%2Finfectious-disease%2Fcovid-19%2F) [![](https://www.idsociety.org/contentassets/6d9bd5c5d90b4071b89b11f5ab2f294b/idsa-logo-green.png)](https://www.idsociety.org/) [![](https://www.idsociety.org/contentassets/6d9bd5c5d90b4071b89b11f5ab2f294b/idsa-logo-green.png)](https://www.idsociety.org/) - Clinical Resources Clinical Resources - Guidelines Guidelines - [A-Z Guideline Listing](https://www.idsociety.org/practice-guideline/all-practice-guidelines/) - [Search All Guidelines](https://www.idsociety.org/practice-guideline/practice-guidelines/) - [Training & Resources](https://www.idsociety.org/clinical-practice-guidelines-development-training-and-resources/) - Featured Guidelines Featured Guidelines - [AMR Guidance](https://www.idsociety.org/practice-guideline/amr-guidance/) - [Community-Acquired Pneumonia in Adults](https://www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults/) - [Complicated Urinary Tract Infections](https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/) - [Skin and Soft Tissue Infections](https://www.idsociety.org/practice-guideline/skin-and-soft-tissue-infections/) - Practice Tools Practice Tools - [Antimicrobial Stewardship](https://www.idsociety.org/practice-resources/practice-tools/antimicrobial-stewardship/) - [Coding and Payment](https://www.idsociety.org/practice-resources/practice-tools/coding-and-payment/) - [ID Physician Compensation](https://www.idsociety.org/practice-resources/professional-development/id-physician-compensation-initiative/) - [Quality Measurement and Improvement](https://www.idsociety.org/practice-resources/practice-tools/quality-measurement-and-improvement/) ![](https://www.idsociety.org/globalassets/new-branding-photos/intern.png?width=420&height=240&format=webp&rxy=0.5%2C0.5&rmode=crop) Guidelines [View all Practice Guidelines](https://www.idsociety.org/practice-guideline/practice-guidelines/) - [Health Topics]() [Health Topics]() - Infectious Diseases Infectious Diseases - [Avian Influenza A(H5N1)](https://www.idsociety.org/ID-topics/infectious-disease/avian-influenza-h5n1/) - [COVID-19](https://www.idsociety.org/ID-topics/infectious-disease/covid-19/) - [Ebola](https://www.idsociety.org/ID-topics/infectious-disease/ebola/) - [Influenza](https://www.idsociety.org/ID-topics/infectious-disease/influenza/) - [Lyme Disease](https://www.idsociety.org/ID-topics/infectious-disease/lyme-disease/) - [Measles](https://www.idsociety.org/ID-topics/infectious-disease/measles/) - [Mpox](https://www.idsociety.org/ID-topics/infectious-disease/mpox/) - [Viral Hepatitis](https://www.idsociety.org/ID-topics/infectious-disease/Viral-hepatitis/) - Special Topics Special Topics - [Antimicrobial Resistance](https://www.idsociety.org/ID-topics/special-topics/antimicrobial-resistance/) - [Climate Change](https://www.idsociety.org/ID-topics/special-topics/climate-change/) - [Emerging Infections](https://www.idsociety.org/ID-topics/infectious-disease/emerging-infections-and-infectious-threats/) - [Hurricanes and Flooding](https://www.idsociety.org/ID-topics/special-topics/hurricane-resources/) - [Immunization & Vaccination](https://www.idsociety.org/ID-topics/special-topics/immunization/) ![](https://www.idsociety.org/globalassets/new-branding-photos/intern.png?width=420&height=240&format=webp&rxy=0.5%2C0.5&rmode=crop) Guidelines [Looking for Practice Guidelines?](https://www.idsociety.org/practice-guideline/all-practice-guidelines/) - Education Education - Professional Development Professional Development - [IDSA Academy](https://academy.idsociety.org/) - [iDMentorship365](https://www.idsociety.org/practice-resources/professional-development/idmentorship365-program/) - [ID STEP Program](https://www.idsociety.org/practice-resources/grants-and-funding/id-spark-train-educate-and-prepare-program/) - [Leadership Institute](https://www.idsociety.org/education--training/idsa-leadership-institute/) - Training and Curriculum Training and Curriculum - [Fellows-in-Training Career Resources](https://www.idsociety.org/education--training/training-and-curriculum/fellows-in-training-resources/) - [ID Fellowship Match](https://www.idsociety.org/education--training/training-and-curriculum/id-fellowship-match/) - [ID Fellowship Training Program Directory](https://www.idsociety.org/education--training/training-and-curriculum/id-fellowship-training-program-directory/) - [Jobs in ID](https://www.idsociety.org/education--training/jobs-in-id/) - [Training Program Director Resources](https://www.idsociety.org/education--training/training-and-curriculum/fellows-in-training-resources/training-program-director-resources/) ![](https://www.idsociety.org/globalassets/new-branding-photos/the-work_06_shot-of-a-young-man-writing-on-a-whiteboard-while-students-look-on.jpg?width=420&height=240&format=webp&quality=100&rxy=0.44%2C0.42&rmode=crop) training [Browse IDSA Academy Courses](https://academy.idsociety.org/) - [Policy & Advocacy]() [Policy & Advocacy]() - Advocacy and Action Advocacy and Action - [Advocacy](https://www.idsociety.org/policy--advocacy/advocacy/) - [Federal Policy Watch](https://www.idsociety.org/policy--advocacy/federal-policy-watch/) - [Take Action](https://idsociety.quorum.us/home_page/) - [Member Advocacy Program](https://www.idsociety.org/policy--advocacy/member-advocacy-program/) - IDSA Policy and Priorities IDSA Policy and Priorities - [Access & Reimbursement](https://www.idsociety.org/policy--advocacy/reimbursement-and-compensation/) - [Antimicrobial Resistance](https://www.idsociety.org/ID-topics/special-topics/antimicrobial-resistance/) - [Diagnostics](https://www.idsociety.org/policy--advocacy/diagnostics/) - [Funding Policy](https://www.idsociety.org/policy--advocacy/funding/) - [Global Health](https://www.idsociety.org/policy--advocacy/global-health/) - Professional Practice Advocacy Professional Practice Advocacy - [Bio-Preparedness Workforce Pilot](https://www.idsociety.org/policy--advocacy/bio-preparedness-workforce-pilot-program/) - [ID Workforce Initiative](https://www.idsociety.org/practice-resources/professional-development/id-workforce/) - [National PrEP Program](https://www.hivma.org/policy--advocacy/professional-practice-advocacy/national-prep-program/) ![](https://www.idsociety.org/globalassets/global-blocks/hero-blocks/hero-3.jpg?width=420&height=240&format=webp&quality=100&rxy=0.5%2C0.5&rmode=crop) Advocacy [Become an IDSA/HIVMA Advocate\!](https://idsociety.quorum.us/home_page/) - [Membership]() [Membership]() - Membership Services Membership Services - [Fellow of IDSA](https://www.idsociety.org/membership-community/fellow-of-idsa/) - [Benefits of Membership](https://www.idsociety.org/membership-community/membership/) - [Join IDSA](https://profile.idsociety.org/s/joinrenewidsa) - [Membership Renewal](https://profile.idsociety.org/s/my-profile/memberships) - [MyIDSA](https://my.idsociety.org/home) - Networking Networking - [Medical Education Community of Practice](https://www.idsociety.org/membership-community/medical-education-community-of-practice/) - [EIN (Emerging Infections Network)](https://ein.idsociety.org/) - [Member Directory](https://my.idsociety.org/network/members) - [Member interest groups](https://www.idsociety.org/membership-community/member-interest-groups/) - [State & Regional Affiliate Program](https://www.idsociety.org/membership-community/state-and-regional-affiliate-program/) - Opportunities Opportunities - [Events](https://www.idsociety.org/event-listing/) - [Funding Opportunities](https://www.idsociety.org/practice-resources/grants-and-funding/funding-alerts/) - [Society Awards](https://www.idsociety.org/about-us/awards/society-awards/) - [Past Award Lecturers](https://www.idsociety.org/about-us/lecturers/past-award-lecturers/) - [Volunteer Opportunities](https://www.idsociety.org/membership-community/volunteer-opportunities/) ![](https://www.idsociety.org/globalassets/idsa/jobs-in-id/idsa_jobseeker_mobile-1.png?width=420&height=240&format=webp&rxy=0.5%2C0.5&rmode=crop) Career [Find your next role in ID\!](https://www.idsociety.org/education--training/jobs-in-id/) - [About](https://www.idsociety.org/about-us/) - [Guidelines](https://www.idsociety.org/practice-guideline/all-practice-guidelines/) - [Journals](https://www.idsociety.org/journals/journals--publications/) - [Events](https://www.idsociety.org/event-listing/) - [Blog](https://www.idsociety.org/science-speaks-blog/) - [News](https://www.idsociety.org/news--publications-new/) - [Login](https://www.idsociety.org/login/?returnUrl=%2FID-topics%2Finfectious-disease%2Fcovid-19%2F) # COVID-19 ![](https://www.idsociety.org/globalassets/idsa/health-topics/covid-19/49535193646_a57e21dcca_o.jpg?width=416&height=416&format=webp&quality=100&rxy=0.5%2C0.5&rmode=crop) Coronavirus disease 2019, or COVID-19, is an infectious disease caused by the SARS-CoV-2 virus. It can be very contagious and can spread quickly. Since 2020, more than 1.2 million people have died of COVID-19 in the U.S. ## More about COVID-19 Symptoms and Treatment People with COVID-19 may have a wide range of symptoms ranging from mild symptoms to severe illness. Possible symptoms include fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting, and diarrhea. Several antiviral medications are available that can reduce risk of hospitalization and death for people with COVID-19 who are more likely to get very sick. To be effective, treatments must be started within five to seven days after symptoms first develop. People who are more likely to get very sick include adults over 65, people who are not vaccinated or not up to date on their COVID-19 vaccinations, or people with certain medical conditions, such as chronic lung disease, heart disease or a weakened immune system. Prevention There are several core prevention strategies that everyone can use to help to protect themselves and others from respiratory viruses, including COVID-19. These include good hygiene (covering your coughs and sneezes, washing or sanitizing your hands often, and cleaning frequently touched surfaces), taking steps for cleaner air and staying home when sick. Staying up to date on COVID-19 vaccines significantly lowers the risk of getting very sick, being hospitalized or dying from COVID-19. The COVID-19 vaccine is recommended for everyone ages 6 months and older and is regularly updated to protect against the currently circulating viral strains. It is especially important to get an updated COVID-19 vaccine if you are aged 65 and older, or if you are at high risk for severe COVID-19. COVID-19 vaccination has also been shown to lower your risk of developing long COVID. Additional strategies like wearing a mask and putting distance between yourself and others can help lower the risk of spreading COVID-19 and other respiratory viruses. Testing for COVID-19 can help you decide what to do next, like getting treatment to reduce your risk of severe illness and taking steps to lower your chances of spreading COVID-19 to others. ## The latest BravoSquared Search [Blog Post Fungi / Fungal Infections Hepatitis JID for Clinicians: Chronic pulmonary aspergillosis, the relationship between HBsAG-ICs and hepatitis flares and more Learn about how autoantibody screening could help identify high-risk patients early for COVID-19 treatment, embedding a TNIC approach in vaccine trial designs and other research ready to inform clinical practice.Last Updated March 19, 2026 Authors Ande Rosado](https://www.idsociety.org/science-speaks-blog/2026/jid-for-clinicians-chronic-pulmonary-aspergillosis-the-relationship-between-hbsag-ics-and-hepatitis-flares-and-more/) [Blog Post COVID-19 Science Speaks Blog Long COVID in India: Clinical patterns, challenges and implications for infectious diseases specialists India’s COVID-19 burden has transitioned from acute pandemic management to long-term sequelae care.Last Updated March 16, 2026 Authors Kaushik Bharati, PhD, FRSPH](https://www.idsociety.org/science-speaks-blog/2026/long-covid-in-india-clinical-patterns-challenges-and-implications-for-infectious-diseases-specialists/) [Blog Post HIV / AIDS COVID-19 JID for Clinicians: On-demand dosing for HIV prevention in women, corticosteroid therapies for cryptococcal meningitis and more Learn more about how vaccination decreased the risk of severe COVID-19 in patients with a history of hematologic malignancy, threats to the diagnostic accuracies of MRSA detection and other research ready to inform clinical practice.Last Updated February 24, 2026 Authors Ande Rosado](https://www.idsociety.org/science-speaks-blog/2026/jid-for-clinicians-on-demand-dosing-for-hiv-prevention-in-women-corticosteroid-therapies-for-cryptococcal-meningitis-and-more/) [Blog Post COVID-19 Vaccines / Immunization Lessons from COVID-19: Vaccine updating and implications for regional health sovereignty The COVID-19 pandemic offers lessons for developing and sustaining vaccine and health sovereignty in Latin America.Last Updated February 20, 2026 Authors Gabriela Zambrano-Sanchez, MD, Luis Del Carpio-Orantes, MD](https://www.idsociety.org/science-speaks-blog/2026/lessons-from-covid-19-vaccine-updating-and-implications-for-regional-health-sovereignty/) More ### For the public [AAP Parenting Website: When Should Kids Get the COVID Vaccine?](https://www.healthychildren.org/English/health-issues/conditions/COVID-19/Pages/when-can-kids-get-the-COVID-vaccine-or-booster.aspx) [AAFP: Fall 2025-2026 Immunization Recommendations](https://www.aafp.org/family-physician/patient-care/prevention-wellness/immunizations-vaccines.html) [ACOG: Maternal Immunization Guidance for COVID-19, Influenza and RSV](https://www.acog.org/news/news-releases/2025/08/acog-releases-updated-maternal-immunization-guidance-covid-influenza-rsv) [IDSA: IDSA releases COVID-19 vaccine guidelines for people who are immunocompromised](https://www.idsociety.org/news--publications-new/articles/2025/idsa-releases-covid-19-vaccine-guidelines-for-people-who-are-immunocompromised/) [CDC: COVID-19](https://www.cdc.gov/covid/) [CDC: Symptoms of COVID-19](https://www.cdc.gov/covid/signs-symptoms/index.html) [CDC: Types of COVID-19 Treatment](https://www.cdc.gov/covid/treatment/index.html) [CDC: Long COVID Basics](https://www.cdc.gov/long-covid/about/index.html) [IDSA: ID Experts: America’s Link Back to Everyday Life](https://www.idsociety.org/globalassets/value-of-id/our-response-to-covid-19/final-covid-action-brief-9.26.22.pdf) ### For clinicians [AAP: Recommended Child and Adolescent Immunization Schedule](https://downloads.aap.org/AAP/PDF/AAP-Immunization-Schedule.pdf) [AAFP: Fall 2025-2026 Immunization Recommendations](https://www.aafp.org/family-physician/patient-care/prevention-wellness/immunizations-vaccines.html) [ACOG: Maternal Immunization Guidance for COVID-19, Influenza and RSV](https://www.acog.org/news/news-releases/2025/08/acog-releases-updated-maternal-immunization-guidance-covid-influenza-rsv) [CDC: COVID Data Tracker](https://covid.cdc.gov/covid-data-tracker/#datatracker-home) [IDSA Guideline: Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza and RSV Infections in Immunocompromised Patients](https://www.idsociety.org/Seasonal-RTI-Vaccinations-in-Immunocompromised-Patients/) [IDSA Guideline: Treatment and Management of Patients With COVID-19](https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/) [IDSA Guideline: Infection Prevention for Health Care Personnel](https://www.idsociety.org/practice-guideline/covid-19-guideline-infection-prevention/) [IDSA Guideline: Molecular Diagnostic Testing](https://www.idsociety.org/practice-guideline/covid-19-guideline-diagnostics/) [IDSA Guideline: Serologic Testing](https://www.idsociety.org/practice-guideline/covid-19-guideline-serology/) [IDSA Guideline: Antigen Testing](https://www.idsociety.org/practice-guideline/covid-19-guideline-antigen-testing/) ![Close Table Of Contents](https://www.idsociety.org/images/close_toc.svg) ### Table of Contents - [More about COVID-19](https://www.idsociety.org/ID-topics/infectious-disease/covid-19/#toc-heading-bclk-58048) - [The latest](https://www.idsociety.org/ID-topics/infectious-disease/covid-19/#toc-heading-bclk-54549) - [For the public](https://www.idsociety.org/ID-topics/infectious-disease/covid-19/#toc-heading-bclk-54326) - [For clinicians](https://www.idsociety.org/ID-topics/infectious-disease/covid-19/#toc-heading-bclk-54327) ![Open Table Of Contents](https://www.idsociety.org/images/open_toc.svg) ![](https://www.idsociety.org/contentassets/6d9bd5c5d90b4071b89b11f5ab2f294b/logo.png) Phone: (703) 299-0200 - About IDSA - [About](https://www.idsociety.org/about-us/) - [Board of Directors](https://www.idsociety.org/about-us/board-of-directors/) - [Contact Us](https://www.idsociety.org/global/contact-us/) - [Jobs in ID](https://www.idsociety.org/education--training/jobs-in-id/) - [Inclusion, Diversity, Access and Equity](https://www.idsociety.org/about-us/inclusion-diversity-access--equity/) - [Industry Relations](https://www.idsociety.org/about-us/industry-relations/) - News & Insights - [Value of ID](https://www.idsociety.org/value-of-id/) - [Science Speaks Blog](https://www.idsociety.org/science-speaks-blog/) - [News](https://www.idsociety.org/news--publications-new/) - [Multimedia](https://www.idsociety.org/multimedia/) - [Journals](https://www.idsociety.org/journals/journals--publications/) - [Events](https://www.idsociety.org/event-listing/) - Membership & Community - [Volunteer Opportunities](https://www.idsociety.org/membership-community/volunteer-opportunities/) - [State & Regional Affiliate Program](https://www.idsociety.org/membership-community/state-and-regional-affiliate-program/) - [Society Awards](https://www.idsociety.org/about-us/awards/society-awards/) - [Member Advocacy Program](https://www.idsociety.org/policy--advocacy/member-advocacy-program/) - [MyIDSA](https://my.idsociety.org/home) - [Member Communities](https://my.idsociety.org/communities/allcommunities) - [Join IDSA](https://www.idsociety.org/membership-community/membership/) - [Linkedin](https://www.linkedin.com/company/idsociety/) - [Facebook](https://www.facebook.com/IDSociety) - [Instagram](https://www.instagram.com/idsainfo/) - [Twitter](https://twitter.com/idsainfo) - [Threads](https://www.threads.net/@idsainfo) - [BlueSky](https://bsky.app/profile/idsainfo.bsky.social) ©2026 Infectious Diseases Society of America - [Terms of Use](https://www.idsociety.org/link/b2335d30fd854d2fa562016520dfc7cc.aspx) - [Privacy Policy](https://www.idsociety.org/link/15ddf31ec52b49eb9b38a308f8ddaed4.aspx) [![](https://www.idsociety.org/globalassets/footer/idweek_green_logo.png)](http://idweek.org/) [![](https://www.idsociety.org/globalassets/new-branding-logos/idsa_fnd_gn.png)](https://www.idsafoundation.org/) [![](https://www.idsociety.org/contentassets/5c603dae86df4e09b9b0101963c08a7d/hivma_2025_gn.png)](http://hivma.org/) [![](https://www.idsociety.org/globalassets/footer/ein_green_logo.png)](https://ein.idsociety.org/)
Readable Markdown	Coronavirus disease 2019, or COVID-19, is an infectious disease caused by the SARS-CoV-2 virus. It can be very contagious and can spread quickly. Since 2020, more than 1.2 million people have died of COVID-19 in the U.S. More about COVID-19 People with COVID-19 may have a wide range of symptoms ranging from mild symptoms to severe illness. Possible symptoms include fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting, and diarrhea. Several antiviral medications are available that can reduce risk of hospitalization and death for people with COVID-19 who are more likely to get very sick. To be effective, treatments must be started within five to seven days after symptoms first develop. People who are more likely to get very sick include adults over 65, people who are not vaccinated or not up to date on their COVID-19 vaccinations, or people with certain medical conditions, such as chronic lung disease, heart disease or a weakened immune system. There are several core prevention strategies that everyone can use to help to protect themselves and others from respiratory viruses, including COVID-19. These include good hygiene (covering your coughs and sneezes, washing or sanitizing your hands often, and cleaning frequently touched surfaces), taking steps for cleaner air and staying home when sick. Staying up to date on COVID-19 vaccines significantly lowers the risk of getting very sick, being hospitalized or dying from COVID-19. The COVID-19 vaccine is recommended for everyone ages 6 months and older and is regularly updated to protect against the currently circulating viral strains. It is especially important to get an updated COVID-19 vaccine if you are aged 65 and older, or if you are at high risk for severe COVID-19. COVID-19 vaccination has also been shown to lower your risk of developing long COVID. Additional strategies like wearing a mask and putting distance between yourself and others can help lower the risk of spreading COVID-19 and other respiratory viruses. Testing for COVID-19 can help you decide what to do next, like getting treatment to reduce your risk of severe illness and taking steps to lower your chances of spreading COVID-19 to others.
Shard	78 (laksa)
Root Hash	11347771854328970478
Unparsed URL	org,idsociety!www,/ID-topics/infectious-disease/covid-19/ s443